Skip to main content
OpenTrials
Completed

NCT Number: NCT01618409

PictureRx: An Intervention to Reduce Latino Health Disparities

The purpose of this randomized controlled trial is to evaluate the effect of Spanish-language illustrated medication instructions (PictureRx cards), compared to traditional medication instructions, on Latinos' understanding of their medication regimens. The study will also assess the effect on self-reported medication adherence. Patients with diabetes who attend participating clinics are eligible. The target sample size is 200.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Medication Adherence Behavior Diabetes Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Health Behavior Metabolic Diseases Nutritional and Metabolic Diseases Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Saint Thomas Family Health Center - South

Nashville, Tennessee, 37211, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diabetes
  • Latino, Spanish speaker
  • Be at least 18 years old
  • Must be taking at least 1 chronic medication

Exclusion criteria

  • Too ill to participate in an interview
  • Do not have a telephone
  • Having visual acuity worse than 20/50 via Rosenbaum Visual Acuity exam (eyechart)
  • Inability to communicate in either Spanish or English
  • Overt psychiatric illnesses, overt delirium or dementia

Treatment and study plan

PictureRx card

Behavioral

An illustrated format of medication instructions that includes pictures of the medications and icons to illustrate their purpose

Primary outcomes

  1. Patient Understanding of their Medication Regimen

    Time frame: Approximately 1 week after enrollment

    The primary outcome will be patients' understanding of their medication regimen, as assessed by an interviewer-administered questionnaire.

Secondary outcomes

  1. Self-reported Adherence

    Time frame: Approximately 1 week after enrollment

    As a secondary outcome, patients will report their self-reported adherence using a validated instrument.

Sponsors and collaborators

Lead sponsor

PictureRx, LLC

Other

Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

Registry information

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Jun 13, 2012
Registry last updated
Jun 13, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.